Atorvastatin and pitavastatin protect cerebellar Purkinje cells in AD model mice and preserve the cytokines MCP-1 and TNF-α

Brain Research

Volumn 1388, Issue , 2011, Pages 32-38

  Kozuki, Miki ^a   Kurata, Tomoko ^a   Miyazaki, Kazunori ^a   Morimoto, Nobutoshi ^a   Ohta, Yasuyuki ^a   Ikeda, Yoshio ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Atorvastatin; Cerebellum; Pitavastatin; Purkinje cell

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ATORVASTATIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PITAVASTATIN; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL MODEL; ARTICLE; CEREBELLUM; CONTROLLED STUDY; DRUG EFFECT; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; SYNAPTIC MEMBRANE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; PURKINJE CELLS; PYRROLES; QUINOLINES; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 79954703774     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.03.024     Document Type: Article

References (40)

1. J.S. Albus A theory of cerebellar function Math. Biosci. 10 1971 25 61
2. N. Arbez, V. Gautheron, B. Brugg, J. Mariani, and C. Rovira Beta-amyloid (1-42) induces a reduction in the parallel fiber responses of Purkinje cells: possible involvement of pro-inflammatory processes Exp. Gerontol. 42 2007 951 962 (Pubitemid 47432736)
3. R.H. Arch, and C.B. Thompson 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB Mol. Cell. Biol. 18 1998 558 565 (Pubitemid 28021066)
4. A.J. Bastian, J.W. Mink, B.A. Kaufman, and W.T. Thach Posterior vermal split syndrome Ann. Neurol. 44 1998 601 610 (Pubitemid 28477847)
5. Y.A. Blednov, S.E. Bergeson, D. Walker, V.M. Ferreira, W.A. Kuziel, and R.A. Harris Perturbation of chemokine networks by gene deletion alters the reinforcing actions of ethanol Behav. Brain Res. 165 2005 110 125 (Pubitemid 41476210)
6. M. Boimel, N. Grigoriadis, A. Lourbopoulos, O. Touloumi, D. Rosenmann, O. Abramsky, and H. Rosenmann Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy J. Neuropathol. Exp. Neurol. 68 2009 314 325
7. J.M. Bower Is the cerebellum sensory for motor's sake, or motor for sensory's sake: the view from the whiskers of a rat Prog. Brain Res. 114 1997 463 496
8. L. Cibickova, R. Hyspler, S. Micuda, N. Cibicek, H. Zivna, D. Jun, A. Ticha, E. Brcakova, and V. Palicka The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain Steroids 74 2009 13 19
9. A. Cordle, and G. Landreth 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses J. Neurosci. 25 2005 299 307 (Pubitemid 40105600)
10. V.T. Cotter The burden of dementia Am. J. Manag. Care Suppl. 8 2007 S193 S197
11. H. Hsu, H.B. Shu, M.G. Pan, and D.V. Goeddel TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways Cell 84 1996 299 308 (Pubitemid 26042835)
12. M.C. Irizarry, J.J. Locascio, and B.T. Hyman β-Site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression andstatic levels with aging Am. J. Pathol. 158 2001 173 177 (Pubitemid 32096482)
13. M. Kaul, G.A. Garden, and S.A. Lipton Pathways to neuronal injury and apoptosis in HIV-associated dementia Nature 410 2001 988 994 (Pubitemid 32335850)
14. J.N. Keller, Z. Pang, J.W. Geddes, J.G. Begley, A. Germeyer, G. Waeg, and M.P. Mattson Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal J. Neurochem. 69 1997 273 284 (Pubitemid 27274182)
15. T. Kido, Y. Tabara, M. Igase, N. Ochi, E. Uetani, T. Nagai, M. Yamamoto, K. Taguchi, T. Miki, and K. Kohara Postural instability is associated with brain atrophy and cognitive impairment in the elderly: the J-SHIPP study Dement. Geriatr. Cogn. Disord. 29 2010 379 387
16. R.H. Knopp Drug treatment of lipid disorders N. Engl. J. Med. 341 1999 498 511 (Pubitemid 29372891)
17. T. Kurata, K. Miyazaki, M. Kozuki, V.L. Panin, N. Morimoto, Y. Ohta, M. Nagai, Y. Ikeda, T. Matsuura, and K. Abe Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice Brain Res. 1371 2011 161 170
18. K.W. Lee, S.H. Lee, H. Kim, J.S. Song, S.D. Yang, S.G. Paik, and P.L. Han Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein J. Neurosci. Res. 76 2004 572 580 (Pubitemid 38580472)
19. H.C. Leiner, A.L. Leiner, and R.S. Dow The human cerebro-cerebellar system: its computing, cognitive, and language skills Behav. Brain Res. 44 1991 113 128
20. L. Li, D. Cao, H. Kim, R. Lester, and K. Fukuchi Simvastatin enhances learning and memory independent of amyloid load in mice Ann. Neurol. 60 2006 729 739 (Pubitemid 46061359)
21. J.K. Liao, and U. Laufs Pleiotropic effects of statins Annu. Rev. Pharmacol. Toxicol. 45 2005 89 118 (Pubitemid 40261799)
22. A.R. Little, S.A. Benkovic, D.B. Miller, and J.P. O'Callaghan Chemically induced neuronal damage and gliosis: enhanced expression of the proinflammatory chemokine, monocyte chemoattractant protein (MCP)-1, without a corresponding increase in proinflammatory cytokines Neuroscience 115 2002 307 320 (Pubitemid 35232709)
23. D.J. Mahad, and R.M. Ransohoff The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE) Semin. Immunol. 15 2003 23 32 (Pubitemid 36092176)
24. H.S. Malhotra, and K.L. Goa Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia Drugs 61 2001 1835 1881 (Pubitemid 32980510)
25. D. Marr A theory of cerebellar cortex J. Physiol. 202 1969 437 470
26. C.M. McManus, J.S. Liu, M.T. Hahn, L.L. Hua, C.F. Brosnan, J.W. Berman, and S.C. Lee Differential induction of chemokines in human microglia by type I and II interferons Glia 29 2000 273 280 (Pubitemid 30079175)
27. S.Z. Meng, A. Oka, and S. Takashima Developmental expression of monocyte chemoattractant protein-1 in the human cerebellum and brainstem Brain Dev. 21 1999 30 35 (Pubitemid 29073343)
28. C.E. Oldreive, and G.H. Doherty Effects of tumour necrosis factor-alpha on developing cerebellar granule and Purkinje neurons in vitro J. Mol. Neurosci. 42 2010 44 52
29. Y. Persidsky, and H.E. Gendelman Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection J. Leukoc. Biol. 74 2003 691 701 (Pubitemid 38040345)
30. D. Pratico, K. Uryu, S. Leight, J.Q. Trojanoswki, and V.M. Lee Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis J. Neurosci. 21 2001 4183 4187 (Pubitemid 32538543)
31. A. Saheki, T. Terasaki, I. Tamai, and A. Tsuji In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors Pharm. Res. 11 1994 305 311 (Pubitemid 24076229)
32. M. Sjöbeck, and E. Englund Alzheimer's disease and the cerebellum: a morphologic study on neuronal and glial changes Dement. Geriatr. Cogn. Disord. 12 2001 211 218 (Pubitemid 32217851)
33. D.L. Sparks, D.J. Connor, P.J. Browne, J.E. Lopez, and M.N. Sabbagh HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier J. Nutr. Health Aging 6 2002 324 331 (Pubitemid 36118981)
34. N. Tanaka, Y. Katayama, T. Katsumata, T. Otori, and Y. Nishiyama Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flox in stroke-prone spontaneously hypertensive rats Brain Res. 169 2007 125 132 (Pubitemid 47381354)
35. W.T. Thach On the specific role of the cerebellum in motor learning and cognition: clues from PET activation and lesion studies in humans Behav. Brain Sci. 19 1996 411 431 (Pubitemid 27121967)
36. D. Timmann, and I. Daum Cerebellar contributions to cognitive functions: a progress report after two decades of research Cerebellum 6 2007 159 162 (Pubitemid 47360072)
37. X.K. Tong, N. Nicolakakis, P. Fernandes, B. Ongali, J. Brouillette, R. Quirion, and E. Hamel Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice Neurobiol. Dis. 35 2009 406 414
38. C.Y. Wang, P.Y. Liu, and J.K. Liao Pleiotropic effects of statin therapy: molecular mechanisms and clinical results Trends Mol. Med. 14 2008 37 44
39. Z.H. Wang, X.L. Liu, M. Zhong, L.P. Zhang, Y.Y. Shang, and X.Y. Hu Pleiotropic effects of atorvastatin on monocytes in atherosclerotic patients J. Clin. Pharmacol. 50 2010 311 319
40. J. Wegiel, H.M. Wisniewski, J. Dziewiatkowski, E. Badmajew, M. Tarnawski, B. Reisberg, B. Mlodzik, M.J. De Leon, and D.C. Miller Cerebellar atrophy in Alzheimer's disease-clinicopathological correlations Brain Res. 818 1999 41 50 (Pubitemid 29227282)